Global Custom Antibody Service Market, by Service Type (Antibody Development, Antibody Production, Downstream Antibody Services, Others (Antibody Purification Services, Antibody Fragmentation and Conjugation and Others)), by Product Type (Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies), by Source (Rabbit, Chicken, Guinea pig, Goat, Mouse, Others (Rat and Others)), by Application (Oncology, Infectious diseases, Immunology, Neurobiology, Stem cells, Other (Cardiovascular Disease and Others)), by End Users (Pharmaceutical & biotechnology companies, Academic & research institutes, Contract research organizations), and by Region (North America, Europe, Asia Pacific, Middle East, Africa, and Latin America) is estimated to be valued at US$ 444.85 Million in 2022 and projected to exhibit a CAGR of 9.7 % during the forecast period (2022-2030).
Market players are focusing on the development of technological advanced antibodies for various research and therapeutic areas. For instance, Merck Group, a science and technology company, announced that its product, ZooMAb, recombinant antibodies offer a new generation of monoclonal antibodies that are specifically engineered and thus decreasing the use of animals in research. The technology enables antibodies to be derived from a wide range of species and eliminates the need for arduous cell fusion and hybridoma construction. Once the gene sequence for the antibody is obtained, it is produced without the need to harm or sacrifice any animals, thus offering an essentially limitless supply of a monoclonal antibody with exceptional batch-to-batch consistency.
Global Custom Antibody Service Market – Impact of Coronavirus (COVID-19) Pandemic
The COVID-19 pandemic has affected various industries globally. Key players operating in the Global Custom Antibody Service Market are facing major challenges on various fronts due to the COVID-19 pandemic. According to the Coronavirus Disease (COVID-19) Weekly Epidemiological Update by the World Health Organization, the number of COVID-19 cases reported globally, as of 18 August 2022, are approximately 590,659,276 confirmed cases with 6,440,163 deaths.
The COVID-19 pandemic has affected the economy in three main ways: by directly affecting the production and demand; by creating disruptions in distribution channels; through its financial impact on firms and financial markets.
Custom antibody services for COVID-19 have increased as a result of research and development activities being conducted by industry participants and academic or research institutions for the treatment of COVID-19. This is expected to positively impact growth of the global custom antibody service market during the COVID-19 pandemic.
Browse 52 Market Data Tables and 47 Figures spread through 227 Pages and in-depth TOC on “Global Custom Antibody Service Market ” - Forecast to 2030, Global Custom Antibody Service Market, by Service Type (Antibody Development, Antibody Production, Downstream Antibody Services, Others (Antibody Purification Services, Antibody Fragmentation and Conjugation and Others)), by Product Type (Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies), by Source (Rabbit, Chicken, Guinea pig, Goat, Mouse, Others (Rat and Others)), by Application (Oncology, Infectious diseases, Immunology, Neurobiology, Stem cells, Other (Cardiovascular Disease and Others)), by End Users (Pharmaceutical & biotechnology companies, Academic & research institutes, Contract research organizations), and by Region (North America, Europe, Asia Pacific, Middle East, Africa, and Latin America) - Forecast to 2030
To know the latest trends and insights prevalent in the Global Custom Antibody Service Market, click the link below:
https://www.coherentmarketinsights.com/market-insight/custom-antibody-service-market-5254
Key Takeaways of the Global Custom Antibody Service Market:
- The global custom antibody service market is expected to exhibit a CAGR of 9.7% during the forecast period, owing to the launch of new services for the production of customized antibodies by key market player, which is expected to drive the growth of the global custom antibody services market over the forecast period. For instance, in 2021, Giotto Biotech, a company that provide information technologies products and services to academic and industrial research groups, launched specialized polyclonal and monoclonal antibody production services. The company facilitates the production of more than 500 monoclonal antibody types that can be used for diagnostic and therapeutic applications. It offers a large choice of species as the sources of polyclonal antibodies.
- Based on service type, the antibody development segment is estimated to account for the largest market share in the global custom antibody service market. Various market players such as Thermo Fisher Scientific, and R&D Systems, Inc. are offering antibody development services, which is expected to drive the segment growth over the forecast period. For instance, R & D Systems, a biotechnology company, offers customized solutions for antibody development and production in many host species. The most common species include mouse, rat, rabbit, goat, sheep, chicken, and llama.
- Major players operating in the global custom antibody service market include Thermo Fisher Scientific, Inc., Genscript, Abcam plc., Cell Signaling Technology, Inc, Bio-Rad Laboratories, Inc., Merck KGaA, Agilent Technologies, Inc., BioLegend, Inc., ROCKLAND IMMUNOCHEMICALS, INC., ProMab, Innovagen AB, ProteoGenix, Bio-Techne., Creative Diagnostics., Sino Biological, Inc., RayBiotech Life, Inc., Abbiotec, Inc., ProSci Incorporated, Capralogics, Inc., and Boster Biological Technology.
